Cargando…

Sickle cell disease: from the beginning until it was recognized as a public health disease

Detalles Bibliográficos
Autor principal:	Naoum, Paulo Cesar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Hematologia e Hemoterapia 2011
Materias:	Scientific Comments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521427/ https://www.ncbi.nlm.nih.gov/pubmed/23284235 http://dx.doi.org/10.5581/1516-8484.20110006

Ejemplares similares

Methemoglobinemia in children: how to explain the results?
por: Naoum, Paulo Cesar
Publicado: (2012)

Sexuality and sickle cell disease
por: Figueiredo, Maria Stella
Publicado: (2013)

Is sickle cell disease the same everywhere?
por: Hankins, Jane
Publicado: (2012)

Oxidative stress in sickle cell disease
por: Queiroz, Raphael Ferreira, et al.
Publicado: (2013)

Comments on renal abnormalities of sickle cell disease
por: Abbud-Filho, Mario
Publicado: (2013)

Sickle cell disease: looking back but towards the future
por: Cançado, Rodolfo Delfini
Publicado: (2012)

Comment on sickle cell disease and left ventricular hypertrophy()
por: Verissimo, Monica Pinheiro de Almeida
Publicado: (2015)

The invisibility of sickle cell disease in Brazil: lessons from a study in Maranhão()
por: Viana, Marcos Borato
Publicado: (2015)

Comment on: “Oral health-related quality of life in children and teens with sickle cell disease”()
por: Correa, Maria Elvira Pizzigatti
Publicado: (2016)

Dynamics of sickle cell disease as one of the determinants of quality of life
por: Ivo, Maria Lúcia, et al.
Publicado: (2013)

Comprehensive healthcare for individuals with sickle cell disease - a constant challenge
por: Cançado, Rodolfo Delfini
Publicado: (2011)

Pregnancy in sickle cell disease – do we know what to expect?()
por: Fertrin, Kleber Yotsumoto
Publicado: (2014)

An eye on sickle cell retinopathy()
por: de Melo, Mônica Barbosa
Publicado: (2014)

Quality of life in sickle cell disease: assessments by the 36-item Short Form Health Survey Questionnaire and Beck Depression Inventory
por: Ivo, Maria Lucia, et al.
Publicado: (2012)

Comments on: molecular matching of red blood cells is superior to serological matching in sickle cell disease patients
por: Nance, Sandra Taddie, et al.
Publicado: (2013)

Oxidative status in sickle cell anemia
por: Magalhães, Silvia Maria Meira
Publicado: (2011)

Nitric oxide status in sickle cell anemia
por: Gonçalves, Romélia Pinheiro
Publicado: (2012)

Fetal hemoglobin and hemolysis markers in sickle cell anemia()
por: Colella, Marina Pereira, et al.
Publicado: (2015)

Adjusting thresholds of serum ferritin for iron deficiency: a moving target()
por: Naoum, Flávio Augusto
Publicado: (2017)

Comment on "The influence of hydroxyurea on oxidative stress in sickle cell anemia"
por: van Beers, Eduard Johannes, et al.
Publicado: (2012)

Sickle cell anemia: clinical diversity and beta S-globin haplotypes
por: Loggetto, Sandra Regina
Publicado: (2013)

Haptoglobin: an emerging candidate for phenotypic modulation of sickle cell anemia?()
por: Santos, Magnun Nueldo Nunes dos
Publicado: (2015)

Gene deletions of glutathione S-transferase and iron status in sickle cell patients
por: Zamaro, Paula Juliana Antoniazzo
Publicado: (2012)

Comment on “Molecular analysis and association with clinical and laboratory manifestations in children with sickle cell anemia”()
por: Souza Goncalves, Marilda
Publicado: (2014)

Comment on “Influence of βS-globin haplotypes and hydroxyurea on tumor necrosis factor-alpha levels in sickle cell anemia”
por: de Souza Torres, Lidiane
Publicado: (2014)

Comment on "The burden and quality of life of caregivers of sickle cell anemia patients taking hydroxyurea versus those not taking hydroxyurea"
por: Souza, José Carlos, et al.
Publicado: (2012)

Comments on: "Impact of iron overload on interleukin-10 levels, biochemical parameters and oxidative stress in patients with sickle cell anemia"
por: Driss, Adel
Publicado: (2013)

The implication of cardio-oncology on Parkinson's disease: answers begin to emerge
por: Scorza, Fulvio A., et al.
Publicado: (2022)

Comment on: Phase I clinical trial of cell therapy in patients with advanced chronic obstructive pulmonary disease: follow-up of up to 3 years
por: Bydlowski, Sergio Paulo
Publicado: (2013)

Hematopoietic stem cell transplantation for Hodgkin's disease
por: Patah, Poliana, et al.
Publicado: (2011)

The Langerhans cell histiocytosis: a disease in search of an identity
por: Rodriguez-Galindo, Carlos
Publicado: (2011)

Mitigating the effect of the COVID-19 pandemic on sickle cell disease services in African countries
por: Dexter, Daniel, et al.
Publicado: (2020)

Recognizing the quiet extinction of invertebrates
por: Eisenhauer, Nico, et al.
Publicado: (2019)

Chorasmia Medical School from the beginning until the Mongol invasion
por: Golshani, Seyyed Alireza, et al.
Publicado: (2015)

Comments on Brazilian workshop model for training investigators in chronic graft-versus-host disease according to the 2005-2006 National Institutes of Health recommendations
por: Lee, Stephanie
Publicado: (2011)

Kidd system antigens and kidney disease()
por: Barros, Melca Maria Oliveira
Publicado: (2017)

Is it the end of the beginning for minimally invasive distal pancreatectomy?
por: McKay, Siobhan C., et al.
Publicado: (2023)

The regulation of artificial intelligence for health in Brazil begins with the General Personal Data Protection Law
por: Dourado, Daniel de Araujo, et al.
Publicado: (2022)

Progress in chronic graft-versus-host disease
por: Martin, Paul J
Publicado: (2011)

Secondary myeloid neoplasias: an emerging group of diseases
por: Hernández-Rivas, Jesús M
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_3vput75t95vb8nbikcde0in4m3